Mechanism of Rosiglitazone in Reducing Liver Ischemia Reperfusion Injury in Rats by Inducing HO-1

Yihan YANG; Huamei CHEN; Yu FANG; Yuxin WANG; Xi ZHAN

doi:10.12259/j.issn.2095-610X.S20240703

Volume 45 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(7): 14-22

Yihan YANG, Huamei CHEN, Yu FANG, Yuxin WANG, Xi ZHAN. Mechanism of Rosiglitazone in Reducing Liver Ischemia Reperfusion Injury in Rats by Inducing HO-1[J]. Journal of Kunming Medical University, 2024, 45(7): 14-22. doi: 10.12259/j.issn.2095-610X.S20240703

Citation:

Yihan YANG, Huamei CHEN, Yu FANG, Yuxin WANG, Xi ZHAN. Mechanism of Rosiglitazone in Reducing Liver Ischemia Reperfusion Injury in Rats by Inducing HO-1[J]. Journal of Kunming Medical University, 2024, 45(7): 14-22. doi: 10.12259/j.issn.2095-610X.S20240703

Citation:

PDF( 1441 KB)

Mechanism of Rosiglitazone in Reducing Liver Ischemia Reperfusion Injury in Rats by Inducing HO-1

doi: 10.12259/j.issn.2095-610X.S20240703

Dept. of Anesthesiology，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2024-03-15
Available Online: 2024-06-14
Publish Date: 2024-07-25

Abstract

Abstract

Objective To observe whether rosiglitazone, a peroxisome proliferator-activated receptor （PPAR-γ） agonist, can attenuate hepatic ischemia-reperfusion injury （IRI） in rats by modulating heme oxygenase 1 （HO-1） activity. Methods A rat 70% hepatic thermal ischemia/reperfusion （I/R） model and hypoxia-glucose deprivation/reperfusion （OGD/R）-induced liver sinusoidal endothelial cells （LSECs） injury model in rats were established. The rats were randomly divided into sham operation group, model group, rosiglitazone pretreatment group and zinc protoporphyrin （ZnPP） group （n = 6/group）. The serum ALT and AST levels of rats were detected by fully automatic biochemical analyzer. HE staining was used to assess liver histopathological injury. PPAR-γ and HO-1 protein expression levels were detected by Western Blot. The cell viability of LSECs was determined by CCK8 method, and reactive oxygen species （ROS） content in LSECs was determined by flow cytometry. Results Compared with the I/R model group, rosiglitazone pretreatment significantly decreased ALT and AST levels, reduced liver cell apoptosis, and alleviated liver tissue IRI （P < 0.01）. WB results showed that rosiglitazone upregulated the expression of PPAR-γ and HO-1protein （P < 0.01）. In addition, compared with the OGD/R model group, rosiglitazone pretreatment （10, 30 μmol/L） improved the survival rate of OGD/ R-induced LSECs and significantly reduced the ROS content in cells in a dose-responsive manner （P < 0.01）. When ZnPP blocked HO-1 activity, the protective effect of rosiglitazone on hepatic IRI in rats disappeared. Conclusion Rosiglitazone can mediate antioxidant and anti-inflammatory effects through up-regulation of HO-1 activity and reduce hepatic IRI in rats.
- Hepatic ischemia reperfusion injury,
- PPAR-γ,
- HO-1,
- Liver sinusoidal endothelial cell

FullText(HTML)

References(30)

References

[1]	Ling S,Jiang G,Que Q,et al. Liver transplantation in patients with liver Failure: Twenty years of experience from China[J]. Liver International : Official Journal of the International Association for the Study of the Liver,2022,42(9) : 2110-2116.
[2]	Guan Y,Yao W,Yi K,et al. Nanotheranostics for the management of hepatic ischemia-reperfusion injury[J]. Small (Weinheim an der Bergstrasse,Germany),2021,17(23):e2007727. doi: 10.1002/smll.202007727
[3]	Gao F,Qiu X,Wang K,Shao C,et al. Targeting the hepatic microenvironment to improve ischemia/reperfusion injury: New insights into the immune and metabolic compartments[J]. Aging and Disease,2022,13(4):1196-1214. doi: 10.14336/AD.2022.0109
[4]	Tang S P,Mao X L,Chen Y H,et al. Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death[J]. Frontiers in Immunology,2022,13:870239. doi: 10.3389/fimmu.2022.870239
[5]	Takada I,Makishima M. Peroxisome proliferator-activated receptor agonists and antagonists: A patent review (2014-Present)[J]. Expert Opinion on Therapeutic Patents,2020,30(1):1-13. doi: 10.1080/13543776.2020.1703952
[6]	Sauer S. Ligands for the nuclear peroxisome proliferator-activated receptor gamma[J]. Trends in Pharmacological Sciences,2015,36(10):688-704. doi: 10.1016/j.tips.2015.06.010
[7]	Katori M,Busuttil R W,Kupiec-Weglinski J W. Heme oxygenase-1 system in organ transplantation[J]. Transplantation,2002,74(7):905-912. doi: 10.1097/00007890-200210150-00001
[8]	Sano N,Tamura T,Toriyabe N,et al. New drug delivery system for liver sinusoidal endothelial cells for ischemia-reperfusion injury[J]. World Journal of Gastroenterology,2015,21(45):12778-12786. doi: 10.3748/wjg.v21.i45.12778
[9]	Yuan B,Ming T,Qu S,et al. The effect of heme oxygenase-1 on liver sinusoidal endothelial cells proliferation and pro-regeneration[J]. Chinese Journal of Hepatobiliary Surgery,2022,28(7):536-541.
[10]	Shen X,Wang M,Bi X,et al. Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR-γ/HO-1 pathways[J]. Molecular Medicine Reports,2016,14(6):5528-5534. doi: 10.3892/mmr.2016.5929
[11]	Abdalla H B,Napimoga M H,Lopes A H,et al. Activation of PPAR-γ induces macrophage polarization and reduces neutrophil migration mediated by heme oxygenase 1[J]. International Immunopharmacology,2020,84(7):106565. doi: 10.1016/j.intimp.2020.106565
[12]	Lhuillier F,Parmantier P,Goudable J,et al. Hepatic ischemia is associated with an increase in liver parenchyma nitric oxide that is in part enzyme-independent[J]. Anesthesiology,2003,98(2):373-378. doi: 10.1097/00000542-200302000-00017
[13]	Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning[J]. American Journal of Physiology Gastrointestinal and Liver Physiology,2003,284(1):G15-26. doi: 10.1152/ajpgi.00342.2002
[14]	Roushansarai N S,Pascher A,Becker F. Innate immune cells during machine perfusion of liver grafts-the janus face of hepatic macrophages[J]. Journal of Clinical Medicine,2022,11(22):6669.
[15]	Kotlinowski J,Jozkowicz A. PPAR-gamma and angiogenesis: endothelial cells perspective[J]. Journal of Diabetes Research,2016,2016:8492353.
[16]	Han X,Wu Y,Yang Q,et al. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis[J]. Pharmacology & Therapeutics,2021,222(6):107791.
[17]	Huang R,Zhang C,Wang X,et al. PPAR-γ in ischemia-reperfusion injury: Overview of the biology and therapy[J]. Frontiers in Pharmacology,2021,12(4):600618. doi: 10.3389/fphar.2021.600618
[18]	Hirao H,Nakamura K,Kupiec-Weglinski J W. Liver ischaemia-reperfusion injury: A new understanding of the role of innate immunity[J]. Nature Reviews Gastroenterology & Hepatology,2022,19(4):239-256.
[19]	Abu-Amara M,Yang S Y,Tapuria N,et al. Liver ischemia/reperfusion injury: Processes in inflammatory networks-a review[J]. Liver transplantation : Official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,2010,16(9): 1016-1032.
[20]	Forman HJ,Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy[J]. Nature Reviews Drug Discovery,2021,20(9):689-709. doi: 10.1038/s41573-021-00233-1
[21]	Linares I,Farrokhi K,Echeverri J,et al. PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model[J]. PloS One,2018,13(4):e0195212. doi: 10.1371/journal.pone.0195212
[22]	Zingarelli B,Chima R,O'Connor M,et al. Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock[J]. American Journal of Physiology Gastrointestinal and Liver Physiology,2010,298(1):G133-141. doi: 10.1152/ajpgi.00262.2009
[23]	R G B,Panisello-Roselló A,Sanchez-Nuno S,et al. Nrf2 and oxidative stress in liver ischemia/reperfusion injury[J]. The FEBS Journal,2022,289(18):5463-5479. doi: 10.1111/febs.16336
[24]	Zhan X,Zhang Z,Huang H,et al. Effect of heme oxygenase-1 on the protection of ischemia reperfusion injury of bile duct in rats after liver transplantation[J]. Clinics and Research in Hepatology and Gastroenterology,2018,42(3):245-254. doi: 10.1016/j.clinre.2017.09.008
[25]	Qu S,Yuan B,Zhang H,et al. Heme oxygenase 1 attenuates hypoxia-reoxygenation injury in mice liver sinusoidal endothelial cells[J]. Transplantation,2018,102(3):426-432. doi: 10.1097/TP.0000000000002028
[26]	Shen X,Wang M,Bi X,et al. Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR-γ/HO-1 pathways[J]. Molecular Medicine Reports,2016,14(6):5528-5534. doi: 10.3892/mmr.2016.5929
[27]	Cho R L,Yang C C,Tseng H C,et al. Heme oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPAR-γ attenuates LPS-mediated lung inflammation[J]. British Journal of Pharmacology,2018,175(20):3928-3946. doi: 10.1111/bph.14465
[28]	Yang Y,Li X,Zhang L,et al. Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPAR/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury[J]. International Journal of Clinical and Experimental Pathology,2015,8(3):2484-2494.
[29]	Yang H,Zhang L,Chen J,et al. Heme oxygenase-1 inhibits the poliferation of hepatic stellate cells by activating PPAR-γ and suppressing Nf-κB[J]. Computational and Mathematical Methods in Medicine,2022,2022:8920861.
[30]	Jang H Y,Hong O Y,Youn H J,et al. 15d-Pgj2 inhibits Nf-κB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism[J]. BMB Reports,2020,53(4):212-217. doi: 10.5483/BMBRep.2020.53.4.164

Relative Articles(20)

Relative Articles

[1]	Guojing LIANG, Kun JI, Kaichun ZHANG, Yufang ZHANG, Jing AN, Yuge ZHANG, Juan WEN, Haiyan REN. The Effect of Probiotics on the Expression of Aβ and the Protective Effect of Neurons in Rats with Cerebral Ischemia-Reperfusion Injury. Journal of Kunming Medical University, 2024, 45(5): 37-43. doi: 10.12259/j.issn.2095-610X.S20240506
[2]	Ziwei ZHANG, Jialin ZHENG, Xiaoyu XU, Hong WANG. Metformin Inhibits high Glucose-induced Vascular Smooth Muscle Cells Proliferation by Promoting Autophagy via AMPK/PPAR-γ. Journal of Kunming Medical University, 2023, 44(10): 60-66. doi: 10.12259/j.issn.2095-610X.S20231026
[3]	Wei YANG, Hongyan CHEN, Wendong CHEN, Yanqiong WANG, Xiangfeng BAI. Effects of miR-208a on Myocardial Ischemia-reperfusion Injury by Regulating the Expression of QKI5 in Rats. Journal of Kunming Medical University, 2022, 43(7): 18-24. doi: 10.12259/j.issn.2095-610X.S20220724
[4]	Feng WANG, Wei YANG, Dianlun QIAN, Song MEI, Wenjie WANG, Kexiang FENG, Xiangfeng BAI. miR-582-5p Regulating Notch1 to Reduce Myocardial Ischemia-reperfusion Injury. Journal of Kunming Medical University, 2022, 43(12): 12-17. doi: 10.12259/j.issn.2095-610X.S20221207
[5]	Jing LUO, Xian-ling GAO, Jian-lin SHAO, Chao ZHANG, Qi ZHANG. Mechanism of Biliverdin in Improving Cerebral Ischemia-reperfusion Injury in Rats. Journal of Kunming Medical University, 2020, 41(11): 1-6. doi: 10.12259/j.issn.2095-610X.S20201107
[6]	Xiao-ying WANG, Zuo-jin LIU, Li-juan SHEN. Review of Correlation between Ischemia-reperfusion Injury and Pyroptosis. Journal of Kunming Medical University, 2020, 41(12): 142-147. doi: 10.12259/j.issn.2095-610X.S20201240
[7]	Ma Xu Dong , Sun Feng , Duan Yong Qing , Wu Xue Song , Li Wei . . Journal of Kunming Medical University, 2019, 40(02): 18-22.
[8]	Wang Zeng Tao , Zhang Jie , Guo Tao . . Journal of Kunming Medical University, 2019, 40(04): 6-10.
[9]	Li Hong Yang , Su Tian Yi , Gong Jian Ping , Gan Ping , Yang Bu Rong , Cun Ying Li , Cha Yong , Zhao Gong Fang . . Journal of Kunming Medical University, 2018, 39(09): 11-14.
[10]	Bian Li Gong , Zhong Lian Mei , Ai Qing Long , Chen Xin Yue , Xu Wen Kai , Yan Run Qi , Qiu Jin , Lu Di . The Anti-antioxidant Role of Ginsenoside Rg1 Regulating Nrf2 on Focal Cerebral Ischemia Reperfusion SD Rats. Journal of Kunming Medical University, 2018, 39(06): 35-38.
[11]	Li Jun Jie . The Gene Expression Change of Inflammatory Factors TNF-α， IL-6 and IL-1βin Cerebral Ischemia-Reperfusion Rats. Journal of Kunming Medical University,
[12]	Zhang Wei . Effect of SGK1 on the Protection of Ischemia Reperfusion Model Rats. Journal of Kunming Medical University,
[13]	Zhang Hai Yan . . Journal of Kunming Medical University,
[14]	Yang Li . . Journal of Kunming Medical University,
[15]	Cao De Jun . . Journal of Kunming Medical University,
[16]	Li Jing Hui . . Journal of Kunming Medical University,
[17]	Shao Jian Lin . . Journal of Kunming Medical University, 2012, 33(04): 1-2.
[18]	. Role of MAPKs in Protection of Hydrogen Sulfide against Lung Injury Following Limb Ischemia-reperfusion in Rats. Journal of Kunming Medical University,
[19]	. Protecton Mechanism of Shuanghuanglian against Liver Ischemia/Reperfusion injury in Rats. Journal of Kunming Medical University,
[20]	Huang Ya . . Journal of Kunming Medical University,